Product Reports Resources Pricing Login Book a demo

GoodRx

Biotech & Life Sciences · Santa Monica, United States · Founded 2011 · IPO 2020

Provides health consumers with convenient and affordable prescription drugs

Valuation $1.35B
Revenue $776M
EBITDA $238M

Talent graph

GoodRx's talent

Book a demo to see the people
Employees mapped 1,074 incl. 33 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 11 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on GoodRx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Global footprint

Where GoodRx has talent and traffic

Workforce by country
20 countries with
team presence
🇺🇸 United States95.7%
🇮🇳 India0.8%
🇧🇷 Brazil0.8%
🇵🇱 Poland0.2%
🇫🇷 France0.1%
Top 5 of 20 shown
Web traffic by country
20M monthly visits
across markets
🇺🇸 United States85.2%
🇨🇦 Canada4%
🇮🇳 India2.7%
🇦🇺 Australia1.7%
🇵🇭 Philippines0.7%
Top 5 markets shown

Patent intelligence

$340k patent portfolio · 3 active families

Estimated portfolio value
$340k
0.03% of market cap · comparable to top peer LetsGetChecked ($403k)
3 active patent families
Where GoodRx innovates DatabaseDrug pricesDrug productMedical educationMedication information

Where GoodRx concentrates vs peers

Each axis is a top-10 topic across GoodRx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

GoodRx's 7 investments and acquisitions.

Every disclosed deal where GoodRx appeared as a backer or acquirer, 2012–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across GoodRx's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where GoodRx deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        GoodRx's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Market sentiment

        What the market is saying about GoodRx

        An AI-synthesized read of the highest-engagement posts about GoodRx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See GoodRx on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.